Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 2 | 2025 | 274 | 0.680 |
Why?
|
| Papilloma | 1 | 2019 | 23 | 0.630 |
Why?
|
| Alphapapillomavirus | 1 | 2019 | 44 | 0.610 |
Why?
|
| Head and Neck Neoplasms | 2 | 2025 | 1075 | 0.520 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2022 | 25 | 0.360 |
Why?
|
| Maxillary Neoplasms | 1 | 2025 | 7 | 0.240 |
Why?
|
| Ameloblastoma | 1 | 2025 | 9 | 0.240 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2025 | 22 | 0.230 |
Why?
|
| Organosilicon Compounds | 1 | 2024 | 5 | 0.230 |
Why?
|
| GTP Phosphohydrolases | 1 | 2025 | 75 | 0.220 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2025 | 41 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2024 | 52 | 0.220 |
Why?
|
| Mouth Mucosa | 1 | 2024 | 68 | 0.220 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2025 | 77 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 170 | 0.210 |
Why?
|
| Indoles | 1 | 2024 | 305 | 0.200 |
Why?
|
| Carcinosarcoma | 1 | 2022 | 24 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 356 | 0.180 |
Why?
|
| Mouth Diseases | 1 | 2021 | 16 | 0.180 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2020 | 14 | 0.170 |
Why?
|
| Papilloma, Inverted | 1 | 2020 | 6 | 0.170 |
Why?
|
| Syphilis | 1 | 2021 | 34 | 0.170 |
Why?
|
| ras Proteins | 1 | 2020 | 133 | 0.160 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2020 | 107 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 155 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1573 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 1308 | 0.160 |
Why?
|
| Carcinoma | 1 | 2022 | 438 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 111 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2025 | 1241 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 289 | 0.150 |
Why?
|
| Mutation | 3 | 2025 | 4212 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 433 | 0.130 |
Why?
|
| Transcriptome | 1 | 2020 | 700 | 0.120 |
Why?
|
| Prevalence | 1 | 2019 | 1298 | 0.120 |
Why?
|
| Genotype | 1 | 2019 | 1865 | 0.110 |
Why?
|
| Humans | 8 | 2025 | 92310 | 0.070 |
Why?
|
| Middle Aged | 3 | 2021 | 27039 | 0.060 |
Why?
|
| Male | 4 | 2025 | 43918 | 0.060 |
Why?
|
| Female | 4 | 2025 | 47889 | 0.060 |
Why?
|
| Vocal Cords | 1 | 2024 | 27 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 51 | 0.060 |
Why?
|
| Papillomaviridae | 1 | 2025 | 165 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2024 | 101 | 0.050 |
Why?
|
| Rabbits | 1 | 2024 | 645 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2025 | 531 | 0.050 |
Why?
|
| Adult | 2 | 2021 | 27534 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 501 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2022 | 16 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 65 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2022 | 86 | 0.050 |
Why?
|
| Aged | 1 | 2019 | 19947 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2024 | 902 | 0.050 |
Why?
|
| beta Catenin | 1 | 2022 | 264 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2025 | 1804 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 2662 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1720 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 2503 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 737 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2450 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1593 | 0.030 |
Why?
|
| Animals | 2 | 2025 | 28059 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1480 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1685 | 0.030 |
Why?
|
| Mice | 1 | 2025 | 12133 | 0.020 |
Why?
|